Blog

BRIEF-Merck KGaA Receives Patent For CRISPR Technology In China – Reuters

BRIEF-Merck KGaA Receives Patent For CRISPR Technology In China
Reuters
BRIEF-Merck KGaA Receives Patent For CRISPR Technology In China. Reuters Staff. 1 Min Read. April 23 (Reuters) – Merck KGaA: * MERCK RECEIVES PATENT FOR CRISPR TECHNOLOGY IN CHINA Source text for Eikon: Further company coverage: (Gdynia Newsroom). Our

2018-04-23 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.